| Product Number : |
CL2156 |
| Product Name : |
Efavirenz |
| CAS No. : |
154598-52-4 |
| Synonyms : |
DMP 266; EFV; L-743726 |
| Chemical Name : |
|
| Molecular Formula : |
C14H9ClF3NO2 |
| Molecular Weight : |
315.68 |
| Molecular Structure : |
 |
| Appearance : |
White crystalline powder |
| Specification : |
98+% |
| Application : |
|
| Registration : |
|
| Storage Condition : |
Efavirenz is a synthetic non-nucleoside reverse transcriptase (RT) inhibitor with antiviral activity. Efavirenz is highly specific and potent allosteric inhibitors of HIV-1 reverse transcriptase. Efavirenz also inhibits the late stages of HIV-1 replication by interfering with HIV-1 Gag-Pol polyprotein processing. It is used as part of highly active antiretroviral therapy for the treatment of a human immunodeficiency virus type 1.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.
